Aug. 28 at 10:08 AM
$ANAB Anaptys Announces Participation in September Investor Conferences
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:
Cantor Global Healthcare Conference 2025, New York, NY
Format – Fireside chat and one-on-one investor meetings
Date and Time – Wednesday, Sept. 3, 2025 at 8:00am ET / 5:00am PT
2025 Wells Fargo Healthcare Conference, Boston, MA
Format – Fireside chat and one-on-one investor meetings
Date and Time – Thursday, Sept. 4, 2025 at 11:00am ET / 8:00am PT
Stifel 2025 Virtual Immunology and Inflammation Forum, Virtual
Format – Fireside chat and one-on-one investor meetings
Date and Time – Tuesday, Sept. 16, 2025 at 12:00pm ET / 9:00am PT